Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Precision Tumor Growth Model Integrating Time-Resolved Flow Cytometry: Predicting Fractionation Efficacy and Immunotherapy Scheduling.

Physics in medicine and biology·2026
Same author

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same author

The mechanism of action and therapeutic potential of macrophages in osteoporosis: from polarization balance to targeted regulation.

Frontiers in immunology·2026
Same author

Programming-voltage-induced interface charge redistribution for a Lu<sub>2</sub>O<sub>3</sub>/Nb:SrTiO<sub>3</sub> deep-ultraviolet photodetector: Achieving reconfigurable logic gates at zero bias.

Journal of colloid and interface science·2026
Same author

Investigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines.

Signal transduction and targeted therapy·2026
Same author

ELP1 gene augmentation restores visual function in a mouse model of familial dysautonomia.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

[Study on <i>In Vitro</i> Chromosome Aberration Test for Nanomaterials and Medical Devices Containing Nanomaterials].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research on the Coordinated Mechanism of Medical Device Research and Evaluation in China and the United States].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research and Countermeasure Analysis on the Classification of Brain-Computer Interface Rehabilitation Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Development of Portable Sleep Monitoring System].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Design and Application of 3D-Printed Individualized Pelvic Prostheses].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Study on Standardization Methods of Multi-Source Heterogeneous Data from ICU Medical Devices Based on openEHR].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.2K

[Study on Circulating Tumor Cell Detection System Based on Microfluidic Chip].

Yuanshuai Di1, Ji Luo1, Dadi Gao1

  • 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032.

Zhongguo Yi Liao Qi Xie Za Zhi = Chinese Journal of Medical Instrumentation
|June 12, 2024
PubMed
Summary
This summary is machine-generated.

This study presents a microfluidic chip for high-throughput detection of circulating tumor cells (CTCs). The system achieves a high detection rate, offering reliable early cancer screening.

Keywords:
circulating tumor cellsearly screeningfluorescence detectionmicrofluidic chipsorting and enrichment

More Related Videos

Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

8.5K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

Related Experiment Videos

Last Updated: Jun 24, 2025

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.2K
Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

8.5K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Microfluidics

Context:

  • Circulating tumor cells (CTCs) are crucial biomarkers for cancer detection and monitoring.
  • Current methods for CTC detection face challenges in throughput and sensitivity.
  • Early cancer screening is vital for improving patient outcomes.

Purpose:

  • To develop and validate a microfluidic chip for efficient sorting, enrichment, and detection of CTCs.
  • To achieve high throughput and a high detection rate for CTCs in peripheral blood.
  • To enable accurate, single-cell level detection of CTCs for early cancer screening.

Summary:

  • A novel microfluidic chip integrating sorting, enrichment, and detection capabilities was designed.
  • CTCs were detected at the single-cell level using a fluorescence detection system.
  • The system achieved a maximum CTC detection rate of 78.6% at an injection rate of 0.2 mL/h, with a correlation coefficient above 0.8.

Impact:

  • The developed CTCs detection system demonstrates high reliability and detection rates.
  • This technology can serve as a valuable tool for clinical research in cancer diagnostics.
  • Provides a foundation for improved early cancer detection and patient management strategies.